Translational Neurodegeneration

Zhentao Zhang et al.

δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities

Naomi P. Visanji, et al.

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

Articles

Recent

Race modifies default mode connectivity in Alzheimer’s disease

Authors: Maria B. Misiura, J. Christina Howell, Junjie Wu, Deqiang Qiu, Monica W. Parker, Jessica A. Turner and William T. Hu

Content type: Research

19 February 2020
Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions

Authors: Seiji Kaji, Takakuni Maki, Tomoyuki Ishimoto, Hodaka Yamakado and Ryosuke Takahashi

Content type: Review

17 February 2020
Reprogrammed astrocytes display higher neurogenic competence, migration ability and cell death resistance than reprogrammed fibroblasts

Authors: Xiaohuan Xia, Chunhong Li, Yi Wang, Xiaobei Deng, Yizhao Ma, Lu Ding and Jialin Zheng

Content type: Short report

8 February 2020
Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays

Authors: Niccolo Candelise, Matthias Schmitz, Katrin Thüne, Maria Cramm, Alberto Rabano, Saima Zafar, Erik Stoops, Hugo Vanderstichele, Anna Villar-Pique, Franc Llorens and Inga Zerr

Content type: Review

17 January 2020
Deep brain stimulation for Tourette’s syndrome

Authors: Wenying Xu, Chencheng Zhang, Wissam Deeb, Bhavana Patel, Yiwen Wu, Valerie Voon, Michael S. Okun and Bomin Sun

Content type: Review

13 January 2020

Most recent articles RSS

View all articles

Editor-in-Chief

Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China

Aims and Scope

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Translational Neurodegeneration

δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

Articles

Race modifies default mode connectivity in Alzheimer’s disease

Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions

Reprogrammed astrocytes display higher neurogenic competence, migration ability and cell death resistance than reprogrammed fibroblasts

Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays

Deep brain stimulation for Tourette’s syndrome

Editor-in-Chief

Aims and Scope

Affiliated with

Annual Journal Metrics

Translational Neurodegeneration

Contact us